The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Rituximab hypersensitivity reactions (HSR): Predictors of recurrent and severe reactions based on severity of reaction, NHL histologic subtype, and burden of disease.
David A Sallman
No relevant relationships to disclose
Eric Macklin
No relevant relationships to disclose
Shihab Ali
No relevant relationships to disclose
James Michaelson
No relevant relationships to disclose
Jeffrey A. Barnes
No relevant relationships to disclose
Jeremy S. Abramson
Consultant or Advisory Role - Genentech
Aleena Banerji
No relevant relationships to disclose
Ephraim P. Hochberg
Consultant or Advisory Role - Genentech